Skip to content
Tenfell
Awarded contract
Published 04 Nov 2021

NHS National Pharmaceuticals Transition 2021_3

NHS England · London

Key facts

Awarded
21 Oct 2021
Contract starts
30 Sep 2021
Contract ends
31 May 2024
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 36 suppliers

SupplierValue
Colonis Pharma Ltd—
Consilient Health Ltd—
CST Pharma Ltd—
Dr Reddy's Laboratories (UK) Ltd—
Pfizer Ltd—
Ranbaxy (UK) Ltd—
Teva UK Ltd—
Aguettant Ltd—
Napp Pharmaceuticals—
Thornton & Ross Ltd—
Wockhardt UK Limited—
Accord-UK Ltd—
Kent Pharma Ltd—
Mylan—
Roche Products Ltd—
Zentiva Pharma UK Ltd—
Amarox Limited—
Brown & Burk UK Ltd—
Day Lewis Medical Ltd—
Drugsrus Ltd—
medac Pharma LLP—
Glenmark Pharmaceuticals Europe Ltd—
Aspire Pharma Ltd—
Mercury Pharmaceuticals Limited—
Panpharma UK Ltd—
Alturix—
Aspen Pharmacare UK Limited—
Kensington Pharma Ltd—
Laboratorio Reig Jofre SA—
Lucane Pharma—
Macure Pharma ApS—
Morningside Pharmaeuticals—
Seacross Pharmaceuticals Ltd—
Torbay Pharmaceuticals—
Cipla (EU) Ltd—
Ambe Medical Group Ltd—

Description

NHS National PharmaceuticalsTransition 2021_3 Offer reference number:CM/PHG/21/5633

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.